Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients

BACKGROUND: Due to the phenotypic and molecular diversity of hepatocellular carcinomas (HCC), it is still a challenge to determine patients’ prognosis. We aim to identify new prognostic markers for resected HCC patients. METHODS: 274 patients were retrospectively identified and samples collected fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Gui-Qi, Yang, Yi, Chen, Er-Bao, Wang, Biao, Xiao, Kun, Shi, Shi-Ming, Zhou, Zheng-Jun, Zhou, Shao-Lai, Wang, Zheng, Shi, Ying-Hong, Fan, Jia, Zhou, Jian, Liu, Tian-Shu, Dai, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582497/
https://www.ncbi.nlm.nih.gov/pubmed/31215439
http://dx.doi.org/10.1186/s12967-019-1946-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582497/
https://www.ncbi.nlm.nih.gov/pubmed/31215439
http://dx.doi.org/10.1186/s12967-019-1946-8

Ejemplares similares